Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 21, 2020 - Issue 7-8
Submit an article Journal homepage
301
Views
7
CrossRef citations to date
0
Altmetric
Brief Report

Levels of clusterin, CD5L, ficolin-3, and gelsolin in ALS patients and controls

Lipsa Mohanty1 UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia and
,
Robert D. Henderson1 UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia and;2 Department of Neurology, Royal Brisbane & Women’s Hospital, Brisbane, Australia
,
Pamela A. McCombe1 UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia and;2 Department of Neurology, Royal Brisbane & Women’s Hospital, Brisbane, AustraliaCorrespondence[email protected]
&
Aven Lee1 UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia and
Pages 631-634 | Received 08 Apr 2020, Accepted 03 Jun 2020, Published online: 19 Jun 2020

References

  • Xu Z, Lee A, Nouwens A, David Henderson R, Ann Mccombe P. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:1–15.
  • Zinkie S, Gentil BJ, Minotti S, Durham HD. Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor. Cell Stress Chaperones. 2013;18:745–58.
  • Brown RA. The effects of clusterin on the aggregation and pathogenicity of TDP-43, a protein implicated in amyotrophic lateral sclerosis [Doctor of philosophy]. University of Wollongong; 2015.
  • Mantovani S, Gordon R, Macmaw JK, Pfluger CM, Henderson RD, Noakes PG, et al. Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood. J Neuroimmunol. 2014;276:213–8.
  • Woodruff TM, Lee JD, Noakes PG. Role for terminal complement activation in amyotrophic lateral sclerosis disease progression. Proc Natl Acad Sci USA. 2014;111:E3–E4.
  • Woodruff T, Denny K, Crane J, Atkin J, Taylor S, Noakes P. Blockade of C5a receptors reduces astroglial inflammation in a rat SOD1G93A model of amyotrophic lateral sclerosis. Mol Immunol. 2008;45:4163.
  • Kuwata K, Watanabe H, Jiang SY, Yamamoto T, Tomiyama-Miyaji C, Abo T, et al. AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice. Am J Pathol. 2003;162:837–47.
  • Wang C, Yosef N, Gaublomme J, Wu C, Lee Y, Clish CB, et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 2015;163:1413–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.